VCA Stocks

Protagonist Pty Ltd, biotechnology company has raised US$9 million (about AUS$11.9 million) to fund the development of new types of therapeutic drugs. The company targets disorders such as asthma, rheumatoid and psoriatic arthritis, gastro-intestinal disorders and diabetes-related conditions. Protagonist Therapeutics is a biotechnology company dedicated to the discovery of novel peptide and small molecule compounds that mimic or inhibit therapeutically-relevant protein-protein interactions.